Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1970 1
1974 1
1976 1
1978 3
1979 3
1980 6
1982 2
1983 5
1984 4
1985 7
1986 9
1987 5
1988 8
1989 3
1990 7
1991 14
1992 8
1993 15
1994 7
1995 2
1996 1
1997 2
1998 5
1999 2
2000 3
2001 3
2002 2
2003 8
2004 6
2005 9
2006 6
2007 2
2008 6
2009 4
2010 2
2011 4
2012 10
2013 10
2014 5
2015 4
2016 7
2017 6
2018 3
2019 2
2020 6
2021 5
2022 12
2023 18
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

250 results

Results by year

Filters applied: . Clear all
Page 1
Stromal gene signatures in large-B-cell lymphomas.
Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J, Vose J, Bast M, Fu K, Weisenburger DD, Greiner TC, Armitage JO, Kyle A, May L, Gascoyne RD, Connors JM, Troen G, Holte H, Kvaloy S, Dierickx D, Verhoef G, Delabie J, Smeland EB, Jares P, Martinez A, Lopez-Guillermo A, Montserrat E, Campo E, Braziel RM, Miller TP, Rimsza LM, Cook JR, Pohlman B, Sweetenham J, Tubbs RR, Fisher RI, Hartmann E, Rosenwald A, Ott G, Muller-Hermelink HK, Wrench D, Lister TA, Jaffe ES, Wilson WH, Chan WC, Staudt LM; Lymphoma/Leukemia Molecular Profiling Project. Lenz G, et al. Among authors: miller tp. N Engl J Med. 2008 Nov 27;359(22):2313-23. doi: 10.1056/NEJMoa0802885. N Engl J Med. 2008. PMID: 19038878 Free PMC article.
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.
Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Montserrat E, López-Guillermo A, Grogan TM, Miller TP, LeBlanc M, Ott G, Kvaloy S, Delabie J, Holte H, Krajci P, Stokke T, Staudt LM; Lymphoma/Leukemia Molecular Profiling Project. Rosenwald A, et al. Among authors: miller tp. N Engl J Med. 2002 Jun 20;346(25):1937-47. doi: 10.1056/NEJMoa012914. N Engl J Med. 2002. PMID: 12075054 Free article.
Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001.
Persky DO, Li H, Stephens DM, Park SI, Bartlett NL, Swinnen LJ, Barr PM, Winegarden JD 3rd, Constine LS, Fitzgerald TJ, Leonard JP, Kahl BS, LeBlanc ML, Song JY, Fisher RI, Rimsza LM, Smith SM, Miller TP, Friedberg JW. Persky DO, et al. Among authors: miller tp. J Clin Oncol. 2020 Sep 10;38(26):3003-3011. doi: 10.1200/JCO.20.00999. Epub 2020 Jul 13. J Clin Oncol. 2020. PMID: 32658627 Free PMC article. Clinical Trial.
Clinical covariates that improve the description of high dose methotrexate pharmacokinetics in a diverse population to inform MTXPK.org.
Taylor ZL, Miller TP, Poweleit EA, DeGroote NP, Pommert L, Awoniyi O, Board SG, Ugboh N, Joshi V, Ambrosino N, Chavana A, Bernhardt MB, Schafer ES, O'Brien MM, Castellino SM, Ramsey LB. Taylor ZL, et al. Among authors: miller tp. Clin Transl Sci. 2023 Nov;16(11):2130-2143. doi: 10.1111/cts.13600. Epub 2023 Aug 3. Clin Transl Sci. 2023. PMID: 37503924 Free PMC article.
Diffuse aggressive lymphoma.
Fisher RI, Miller TP, O'Connor OA. Fisher RI, et al. Among authors: miller tp. Hematology Am Soc Hematol Educ Program. 2004:221-36. doi: 10.1182/asheducation-2004.1.221. Hematology Am Soc Hematol Educ Program. 2004. PMID: 15561685 Review.
NCAM (CD56)-positive malignant lymphoma.
Kern WF, Spier CM, Miller TP, Grogan TM. Kern WF, et al. Among authors: miller tp. Leuk Lymphoma. 1993 Dec;12(1-2):1-10. doi: 10.3109/10428199309059565. Leuk Lymphoma. 1993. PMID: 7512851 Review.
Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas.
Fisher RI, Longo DL, DeVita VT Jr, Hubbard SM, Miller TP, Young RC. Fisher RI, et al. Among authors: miller tp. Ann Oncol. 1991 Jan;2 Suppl 1:33-5. doi: 10.1093/annonc/2.suppl_1.33. Ann Oncol. 1991. PMID: 1710487 Free article. Review.
Management of intermediate-grade lymphomas.
Miller TP. Miller TP. Oncology (Williston Park). 1998 Oct;12(10 Suppl 8):35-9. Oncology (Williston Park). 1998. PMID: 9830631 Free article. Review.
Data standards in pediatric oncology: Past, present, and future.
Wyatt KD, Noyd DH, Wood NM, Phillips CA, Miller TP, Rubin EM, Winestone LE, Waanders AJ, Perentesis JP, Aplenc R. Wyatt KD, et al. Among authors: miller tp. Pediatr Blood Cancer. 2023 Feb;70(2):e30128. doi: 10.1002/pbc.30128. Epub 2022 Dec 10. Pediatr Blood Cancer. 2023. PMID: 36495256
250 results